PPPDE2 Activators
PPPDE2 Activators, also known as Phosphatase Polyphosphatase Domain-Containing Enzyme 2 Activators, constitute a class of compounds with a specific biochemical function. These activators are involved in regulating cellular processes by modulating the activity of the PPPDE2 enzyme. PPPDE2 is a phosphatase polyphosphatase domain-containing enzyme found within cells, primarily in the cytoplasm and nucleus. It plays a pivotal role in various cellular functions, although its precise mechanisms are still under investigation.
The PPPDE2 Activators are characterized by their ability to interact with PPPDE2 and enhance its enzymatic activity. This interaction can result in the dephosphorylation of specific substrates within the cell, leading to downstream effects on cellular signaling pathways. These activators are believed to have a regulatory role in processes such as signal transduction, cellular growth, and metabolism. While the exact molecular structure of PPPDE2 Activators can vary, their common feature is their ability to modulate the activity of PPPDE2. Understanding the mechanisms by which these activators function and their specific roles within different cellular contexts is an ongoing area of research in the field of molecular biology and biochemistry. Further exploration of PPPDE2 Activators may shed light on their contributions to cellular homeostasis and potentially reveal novel insights into cellular regulation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels. Elevated cAMP activates PKA, which can phosphorylate and regulate various proteins. As PPPDE2 is a peptidase potentially regulated by phosphorylation, increased PKA activity may enhance PPPDE2 activity through direct or indirect phosphorylation events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC), which phosphorylates a broad range of cellular targets. PKC-mediated phosphorylation can modulate protein peptidases like PPPDE2, potentially enhancing its enzymatic activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, triggering calcium-dependent signaling pathways. Calcium signaling can modulate protease activity, potentially affecting PPPDE2 function indirectly by altering its substrate or regulatory protein interactions. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. By mimicking cAMP and activating PKA, 8-Bromo-cAMP could enhance PPPDE2 activity if PPPDE2 is a target or is regulated by PKA-dependent phosphorylation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases can lead to increased phosphorylation levels of cellular proteins. PPPDE2 activity could be indirectly enhanced by the accumulation of phosphorylated proteins that interact with or regulate PPPDE2. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that can induce the c-Jun N-terminal kinase pathway, potentially influencing proteins involved in peptidase regulation. PPPDE2 could be indirectly activated by JNK-mediated signaling events that affect its function. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is another inhibitor of protein phosphatases, particularly PP1 and PP2A. Similar to okadaic acid, it can cause an increase in phosphorylated proteins within the cell, potentially enhancing the activity of PPPDE2 by modulating its interaction with other proteins. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium levels, activating calcium-dependent signaling cascades. These signaling events could indirectly enhance PPPDE2 activity by affecting the cellular context in which PPPDE2 operates. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to an increase in cAMP levels. By raising cAMP, Rolipram indirectly enhances PKA activity, which may in turn modulate PPPDE2 activity through phosphorylation-dependent mechanisms. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, but at low concentrations, it can act selectively on certain kinases. This selective inhibition could shift the balance of cellular phosphorylation in a way that indirectly activates PPPDE2. | ||||||